Trials / Completed
CompletedNCT02729012
Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study
Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With Allergic Rhinitis. RinASol- Pilot Study (Allergic Rhinitis Solution)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Stefania La Grutta, MD · Academic / Other
- Sex
- All
- Age
- 6 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of RinASol project is to assess in patients with seasonal Allergic Rhinitis the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on nasal inflammation by means of nasal cytology. The secondary objective is the symptom score assessment by T5SS Questionnaire (Total Symptom Score 5)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hypertonic saline solution (NACL 3%+NAHCO3) | Treatment with nebulized hypertonic saline solution (NACL 3%+NAHCO3) |
| OTHER | Saline Solution (NACL 0,9%) | Treatment with nebulized Saline Solution (NACL 0,9%) |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-04-06
- Last updated
- 2017-01-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02729012. Inclusion in this directory is not an endorsement.